Freeline Therapeutics Holdings Plc – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 12/31/22 FY 2022

ended 12/31/21 FY 2021

ended 12/31/20 FY 2020

Prospectuses and Registrations Filter

Securities registration termination

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Ownership Filter

Syncona Portfolio Ltd

Eventide Asset Management, LLC

Integrated Core Strategies (US) LLC

Tetragon Financial Management LP

Syncona Portfolio Ltd

News Filter

Acquisition of Freeline by Syncona Becomes Effective

Shareholders Approve Acquisition by Syncona

Material disclosure

Reports Second Quarter 2023 Financial Results and Business Highlights

Certain Information in This Exhibit Identified by [***] Is

Proxies

No filings in this category.

Other Filter

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness